TRISTEL plc
("Tristel" or the "Company ")
Trading update, overseas expansion and results date
Tristel plc, the infection and contamination control business, is pleased to provide a trading update.
Tristel continues to see strong growth across the Group and trading results for the year ended 30 June 2010 are expected to be in line with market expectations.
In addition the Company announces that it has established a branch office in Berlin, Germany. The Company has already commenced sales in Germany, Europe's largest healthcare market, and has introduced its Wipes System to Ear, Nose & Throat and Cardiology departments and its Stella decontamination system to Urology departments in hospitals.
More detail on the Company's geographical expansion will be given in the preliminary announcement of results for the year ended 30 June 2010. The Company will announce its results on 18 October 2010.
For further information, please contact:
|
Tristel PLC |
|
|
Paul Swinney, Chief Executive |
Tel: 01638 721 500 |
|
Walbrook PR Ltd |
Tel: 020 7933 8787 |
|
Paul McManus |
Mob: 07980 541 893 |
|
paul.mcmanus@walbrookpr.com |
|
|
FinnCap |
|
|
Geoff Nash/Rhydian Bankes (Corporate Finance) |
Tel: 020 7600 1658 |
|
Simon Starr (Corporate Broking) |
This information is provided by RNS